EU gives conditional approval to Kimberly‑Clark’s acquisition of Kenvue

On 13 October 2026 the European Commission approved Kimberly‑Clark’s purchase of Kenvue, but only if the company sells its tampon and feminine‑hygiene brands in the European Economic Area. The divestiture is to be made to Turkish firm Dilek. The approval removes the regulatory hurdle for the deal.

The conditional clearance allows the $40‑$48.7 billion transaction to proceed, subject to the brand divestments, which could affect the competitive landscape in European personal‑care markets and impact the valuation of both KMB and KVUE.

  • 1The European Commission granted conditional approval on 13 October 2026.
  • 2Kimberly‑Clark must divest its tampon and feminine‑hygiene brands in the EEA, including Kotex, Camelia and Record.
  • 3The divested assets will be sold to Turkish company Dilek.
  • 4Several sources state the acquisition value as $40 billion.
  • 5Other sources report the acquisition value as $48.7 billion.
  • Deal value is reported as $40 billion and $48.7 billion.

Sources